NCT02807181 - SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 14, 2017

Primary Completion Date

April 29, 2021

Study Completion Date

April 29, 2021

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

DRUG

Cisplatin-gemcitabine

Systemic chemotherapy

DEVICE

Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)

SIR-Spheres microspheres followed by systemic chemotherapy

Trial Locations (23)

1105

AMC Academic Medical Center, Amsterdam

1200

Cliniques Universitaires Saint-Luc, Brussels

2109

Macquarie University Hospital, North Ryde

3000

Peter MacCallum Cancer Centre, Melbourne

13009

Institut Paoli Calmettes, Marseille

21079

CHU Dijon, Dijon

31008

Clinica Universitaria de Navarra, Pamplona

33604

Hopital Haut-Leveque, Pessac

34295

CHU Montpellier, Montpellier

35042

Centre Eugene Marquis Hospital de Jour, Rennes

38043

CHU de Grenoble, Grenoble

56126

U.O. Oncologia Medica 2 Universitaria, Pisa

69317

CHU Lyon - Hospital de la Croix-Rousse, Lyon

86021

CHU de Poitiers, Poitiers

92110

Hopital Beaujon, Clichy

94800

Hopital Paul Brousse, Villejuif

99204

Providence Health Care, Spokane

06202

CHU Nice - Hopital l'Archet 2, Nice

08036

Hospital Clinic Barcelona, Barcelona

W12 0HS

Hammersmith Hospital Imperial College Healthcare NHS Trust, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

CH63 4JY

The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral

S016 6YD

Southampton General Hospital, Southampton